Medications

FDA approves cablivi for rare blood-clotting disorder

(HealthDay)—Cablivi (caplacizumab-yhdp) injection has been approved by the U.S. Food and Drug Administration to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP).

Cardiology

Experimental vaccine may reduce post-stroke blood clot risk

A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to ...

Cardiology

Experimental vaccine may reduce post-stroke blood clot risk

A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to ...

Cardiology

Diagnostic device can prevent strokes and heart attacks

A team of engineers and biochemists at ANU has invented and trialled a bio-optics diagnostic device that can reveal the formation of blood clots and help doctors to identify patients at imminent risk of having a stroke or ...

Cardiology

Depression linked to common heart rhythm disorder

Depression may increase the risk for atrial fibrillation, the most common heart rhythm disorder that can lead to blood clot formation and stroke, according to preliminary research presented at the American Heart Association's ...

Immunology

Mechanism behind autoimmune disorder revealed

Northwestern Medicine scientists discovered a previously-unknown mechanism of disease behind a specific autoimmune disorder, findings published in the Proceedings of the National Academy of Sciences.

page 1 from 6